Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock
- 26 November 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 222 (1) , 13-19
- https://doi.org/10.1016/0014-2999(92)90456-e
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Platelet activating factor involvement in splanchnic artery occlusion shock in ratsEuropean Journal of Pharmacology, 1991
- Effects of fructose 1,6-diphosphate on splanchnic artery occlusion shock in the ratResuscitation, 1989
- Platelet-activating factor and cytokine interactions in shockResuscitation, 1989
- Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shockThrombosis Research, 1989
- Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shockProstaglandins, Leukotrienes & Essential Fatty Acids, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Prostaglandins, Leukotrienes, and Platelet-Activating Factor in ShockAnnual Review of Pharmacology and Toxicology, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogsEuropean Journal of Pharmacology, 1983
- A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitroJournal of Immunological Methods, 1977